Adrián González-González

Pfizer-University of Granada-Junta de Andalucía Centre for Genomics and Oncological Research — Spain

Biochemistry, Genetics and Molecular Biology · Life Sciences

5h-index275citations22works2.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

TGF-β signaling in diseases(12), Mechanisms of cancer metastasis(12), Cancer-related gene regulation(6), Cancer Cells and Metastasis(4), Kruppel-like factors research(4)

Publications22 total

Signature-based repurposed drugs resemble the inhibition of TGFβ-induced NDRG1 as potential therapeutics for triple-negative breast cancer
International Journal of Biological Sciences·2025· 2 citedOpen Access
Supplementary Figure S1 from Activating Transcription Factor 4 Modulates TGFβ-Induced Aggressiveness in Triple-Negative Breast Cancer via SMAD2/3/4 and mTORC2 Signaling
2023Open Access
Supplementary Information_clean version from Activating Transcription Factor 4 Modulates TGFβ-Induced Aggressiveness in Triple-Negative Breast Cancer via SMAD2/3/4 and mTORC2 Signaling
2023Open Access
Supplementary Table S2 from Activating Transcription Factor 4 Modulates TGFβ-Induced Aggressiveness in Triple-Negative Breast Cancer via SMAD2/3/4 and mTORC2 Signaling
2023Open Access
Supplementary Table S1 from Activating Transcription Factor 4 Modulates TGFβ-Induced Aggressiveness in Triple-Negative Breast Cancer via SMAD2/3/4 and mTORC2 Signaling
2023Open Access
Supplementary Figure S1 from Activating Transcription Factor 4 Modulates TGFβ-Induced Aggressiveness in Triple-Negative Breast Cancer via SMAD2/3/4 and mTORC2 Signaling
2023Open Access
Supplementary Figure S3 from Activating Transcription Factor 4 Modulates TGFβ-Induced Aggressiveness in Triple-Negative Breast Cancer via SMAD2/3/4 and mTORC2 Signaling
2023Open Access
Supplementary Table S3 from Activating Transcription Factor 4 Modulates TGFβ-Induced Aggressiveness in Triple-Negative Breast Cancer via SMAD2/3/4 and mTORC2 Signaling
2023Open Access
Supplementary Table S1 from Activating Transcription Factor 4 Modulates TGFβ-Induced Aggressiveness in Triple-Negative Breast Cancer via SMAD2/3/4 and mTORC2 Signaling
2023Open Access
Supplementary Table S3 from Activating Transcription Factor 4 Modulates TGFβ-Induced Aggressiveness in Triple-Negative Breast Cancer via SMAD2/3/4 and mTORC2 Signaling
2023Open Access
Supplementary Figure S2 from Activating Transcription Factor 4 Modulates TGFβ-Induced Aggressiveness in Triple-Negative Breast Cancer via SMAD2/3/4 and mTORC2 Signaling
2023Open Access
Data from Activating Transcription Factor 4 Modulates TGFβ-Induced Aggressiveness in Triple-Negative Breast Cancer via SMAD2/3/4 and mTORC2 Signaling
2023Open Access
Supplementary Information_clean version from Activating Transcription Factor 4 Modulates TGFβ-Induced Aggressiveness in Triple-Negative Breast Cancer via SMAD2/3/4 and mTORC2 Signaling
2023Open Access
Data from Activating Transcription Factor 4 Modulates TGFβ-Induced Aggressiveness in Triple-Negative Breast Cancer via SMAD2/3/4 and mTORC2 Signaling
2023Open Access
Supplementary Figure S3 from Activating Transcription Factor 4 Modulates TGFβ-Induced Aggressiveness in Triple-Negative Breast Cancer via SMAD2/3/4 and mTORC2 Signaling
2023Open Access
Supplementary Figure S2 from Activating Transcription Factor 4 Modulates TGFβ-Induced Aggressiveness in Triple-Negative Breast Cancer via SMAD2/3/4 and mTORC2 Signaling
2023Open Access
Supplementary Table S2 from Activating Transcription Factor 4 Modulates TGFβ-Induced Aggressiveness in Triple-Negative Breast Cancer via SMAD2/3/4 and mTORC2 Signaling
2023Open Access
TGFβ Governs the Pleiotropic Activity of NDRG1 in Triple-Negative Breast Cancer Progression
International Journal of Biological Sciences·2022· 20 citedOpen Access
Antioxidants for the Treatment of Breast Cancer: Are We There Yet?
Antioxidants·2021· 88 citedOpen Access
Drug Repurposing for Triple-Negative Breast Cancer
Journal of Personalized Medicine·2020· 46 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

Francisca E. Cara(22), Sergio Granados‐Principal(22), Juan Antonio Marchal(21), José A. Lorente(20), Pedro Sánchez‐Rovira(19), Esperanza Muñoz‐Muela(18), Maria P. Molina(18), Marina Cruz-Lozano(18), Rafael J. Luque(18), Carmen Rosa‐Garrido(18), César L. Ramírez-Tortosa(18), Jenny C. Chang(18), Gema Jiménez(17), Akanksha Verma(17), Anthony J. Kozielski(17), Olivier Elemento(17), María D. Martín-Salvago(17), David Landeira(17), María Quintana-Romero(17), Roberto R. Rosato(17)